74 related articles for article (PubMed ID: 23108357)
1. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
VanCott JL; Prada AE; McNeal MM; Stone SC; Basu M; Huffer B; Smiley KL; Shao M; Bean JA; Clements JD; Choi AH; Ward RL
J Virol; 2006 May; 80(10):4949-61. PubMed ID: 16641286
[TBL] [Abstract][Full Text] [Related]
2. Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers.
Huo Z; Bissett SL; Giemza R; Beddows S; Oeser C; Lewis DJ
PLoS One; 2012; 7(3):e33736. PubMed ID: 22438987
[TBL] [Abstract][Full Text] [Related]
3. Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma.
Cantarella G; Liniger M; Zuniga A; Schiller JT; Billeter M; Naim HY; Glueck R
Vaccine; 2009 May; 27(25-26):3385-90. PubMed ID: 19200837
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization.
Barackman JD; Ott G; Pine S; O'Hagan DT
Clin Diagn Lab Immunol; 2001 May; 8(3):652-7. PubMed ID: 11329476
[TBL] [Abstract][Full Text] [Related]
5. Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization.
Kang TJ; Loc NH; Jang MO; Jang YS; Kim YS; Seo JE; Yang MS
Transgenic Res; 2003 Dec; 12(6):683-91. PubMed ID: 14713197
[TBL] [Abstract][Full Text] [Related]
6. Chloroplast display of subunit vaccines and their efficacy via oral administration.
Han J; Zhang J; Hu L; Wang C; Wang S; Miao G
Int J Biol Macromol; 2024 Feb; 258(Pt 2):129125. PubMed ID: 38163512
[TBL] [Abstract][Full Text] [Related]
7. Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.
Pitcovski J; Gruzdev N; Abzach A; Katz C; Ben-Adiva R; Brand-Shwartz M; Yadid I; Ratzon-Ashkenazi E; Emquies K; Israeli H; Haviv H; Rapoport I; Bloch I; Shadmon R; Eitan Z; Eliahu D; Hilel T; Laster M; Kremer-Tal S; Byk-Tennenbaum T; Shahar E
Vaccine; 2022 Feb; 40(8):1098-1107. PubMed ID: 35078662
[TBL] [Abstract][Full Text] [Related]
8. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development.
Shanmugaraj B; Malla A; Phoolcharoen W
Pathogens; 2020 Feb; 9(2):. PubMed ID: 32098302
[TBL] [Abstract][Full Text] [Related]
9. A multi-epitope plant-made chimeric protein (LTBentero) targeting common enteric pathogens is immunogenic in mice.
Trujillo E; Rosales-Mendoza S; Angulo C
Plant Mol Biol; 2020 Jan; 102(1-2):159-169. PubMed ID: 31820286
[TBL] [Abstract][Full Text] [Related]
10. Review of Newly Identified Functions Associated With the Heat-Labile Toxin of Enterotoxigenic
Duan Q; Xia P; Nandre R; Zhang W; Zhu G
Front Cell Infect Microbiol; 2019; 9():292. PubMed ID: 31456954
[TBL] [Abstract][Full Text] [Related]
11. Reconceptualizing cancer immunotherapy based on plant production systems.
Hefferon K
Future Sci OA; 2017 Aug; 3(3):FSO217. PubMed ID: 28884013
[TBL] [Abstract][Full Text] [Related]
12. Using transgenic plants and modified plant viruses for the development of treatments for human diseases.
Loh HS; Green BJ; Yusibov V
Curr Opin Virol; 2017 Oct; 26():81-89. PubMed ID: 28800551
[TBL] [Abstract][Full Text] [Related]
13. LTB-Syn: a recombinant immunogen for the development of plant-made vaccines against synucleinopathies.
Arevalo-Villalobos JI; Govea-Alonso DO; Monreal-Escalante E; Zarazúa S; Rosales-Mendoza S
Planta; 2017 Jun; 245(6):1231-1239. PubMed ID: 28315001
[TBL] [Abstract][Full Text] [Related]
14. Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells.
Ríos-Huerta R; Monreal-Escalante E; Govea-Alonso DO; Angulo C; Rosales-Mendoza S
Plant Cell Rep; 2017 Feb; 36(2):355-365. PubMed ID: 27942840
[TBL] [Abstract][Full Text] [Related]
15. Edible plants for oral delivery of biopharmaceuticals.
Merlin M; Pezzotti M; Avesani L
Br J Clin Pharmacol; 2017 Jan; 83(1):71-81. PubMed ID: 27037892
[TBL] [Abstract][Full Text] [Related]
16. Plant-made oral vaccines against human infectious diseases-Are we there yet?
Chan HT; Daniell H
Plant Biotechnol J; 2015 Oct; 13(8):1056-70. PubMed ID: 26387509
[TBL] [Abstract][Full Text] [Related]
17. The increasing value of plant-made proteins.
Sack M; Hofbauer A; Fischer R; Stoger E
Curr Opin Biotechnol; 2015 Apr; 32():163-170. PubMed ID: 25578557
[TBL] [Abstract][Full Text] [Related]
18. Plant-based vaccines against viruses.
Rybicki EP
Virol J; 2014 Dec; 11():205. PubMed ID: 25465382
[TBL] [Abstract][Full Text] [Related]
19. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice.
Hongli L; Xukui L; Ting L; Wensheng L; Lusheng S; Jin Z
Hum Vaccin Immunother; 2013 Jan; 9(1):83-9. PubMed ID: 23108357
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
